GlassScriptPhysician profile
Ahmed Elsayed Rezk
NPI 1184838187
$1,673.39
in general payments reported to CMS, 2019-2025
18 companies · $242 in 2025
The $242 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $61.62 · 2021: $80.81 · 2022: $194 · 2023: $299 · 2024: $579 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $420.65 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $292.21 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $145.44 | 2022-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Tris Pharma INC | $98.76 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $91.62 | 2021-2025 | Azstarys |
| Pfizer INC. | $88.59 | 2019-2023 | |
| Glaxosmithkline, LLC. | $79.22 | 2020-2024 | Bexsero |
| Collegium Pharmaceutical, INC. | $71.13 | 2025 | Jornay Pm |
| Nestle Healthcare Nutrition INC. | $68.15 | 2022-2023 | |
| Sobi, INC | $59.59 | 2019-2023 | |
| Sanofi Pasteur INC. | $56.55 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $44.24 | 2024 | Daybue |
| Seqirus USA INC | $37.58 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Abbott Laboratories | $35.66 | 2019-2020 | |
| Pharming Healthcare, INC. | $29.21 | 2024 | Ruconest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $21.44 | 2019 | |
| Kaleo, INC. | $20.85 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Rezk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.